BioCurex, Inc.(fka BOCX)

[opportunityknocking]

This is quite important to put an end to the mischaracterization of recaf. Goldseeker (who has no medical background whatsoever) compares recaf to Haah. Everyone that understands that recaf picked up EARLY cancer understands the value of this. Mata points out, "I was grateful to see one of our prolific posters posting that pr from panacea. wow. 50% of the the cancer samples were stage 3 and 4 and NO SAMPLES WITH BENIGN TUMOR GROWTH. No wonder haah is not generating any interest."

Doesn't that bode well for our 510(k) which IMO Dr Moro is not wasting any time obtaining? A predicate is all we need and if they allowed AMDL and haah we are looking at 6 months after submission (this year).

Thanks Half for pointing out the buys that Gold cleverly forgot to mention. It seems brand "goldseeker" needs a makeover. Even Zolax who also never had anything positive to say told goldseeker to move on. That was the first time I agreed with Zolax. That is some sound advice.